A pilot study to evaluate the co-infusion of ex vivo expanded umbilical cord blood progenitors with an unmanipulated cord blood graft in patients undergoing umbilical cord blood transplantation for hematologic malignancies.

Trial Profile

A pilot study to evaluate the co-infusion of ex vivo expanded umbilical cord blood progenitors with an unmanipulated cord blood graft in patients undergoing umbilical cord blood transplantation for hematologic malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Feb 2015

At a glance

  • Drugs Haematopoetic stem cell therapy Nohla Therapeutics (Primary) ; Ciclosporin; Ciclosporin; Cyclophosphamide; Fludarabine; Mycophenolate mofetil; Mycophenolate mofetil
  • Indications Graft-versus-host disease; Haematological malignancies
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 10 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 10 Jul 2013 Planned end date changed from 1 Aug 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
    • 14 Jan 2013 Planned end date changed from 1 Aug 2012 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top